These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3700224)

  • 1. Response of pups to modified-live canine parvovirus component in a combination vaccine.
    O'Brien SE; Roth JA; Hill BL
    J Am Vet Med Assoc; 1986 Apr; 188(7):699-701. PubMed ID: 3700224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serologic response of pups to the low-passage, modified-live canine parvovirus-2 component in a combination vaccine.
    O'Brien SE
    J Am Vet Med Assoc; 1994 Apr; 204(8):1207-9. PubMed ID: 8014088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of two canine parvovirus vaccines for inducing seroconversion in Rottweiler and Doberman pinscher pups with various levels of maternally derived antibodies.
    Coyne MJ
    Vet Ther; 2000; 1(1):35-42. PubMed ID: 19757563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A modified live canine parvovirus vaccine. II. Immune response.
    Carmichael LE; Joubert JC; Pollock RV
    Cornell Vet; 1983 Jan; 73(1):13-29. PubMed ID: 6337780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of puppies to canine-origin parvovirus vaccines.
    Carmichael LE; Pollock RV; Joubert JC
    Mod Vet Pract; 1984 Feb; 65(2):99-102. PubMed ID: 6328258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intranasal vaccination of pups in the presence of maternally derived antibodies to canine parvovirus (CPV). Evaluation of minimal immunizing dose.
    Buonavoglia C; Cavalli A; Tempesta M; Voight V; Buonavoglia D; Corrente M; Sagazio P
    New Microbiol; 1995 Oct; 18(4):371-5. PubMed ID: 8590389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of selected canine vaccines for their ability to induce protective immunity against canine parvovirus infection.
    Larson LJ; Schultz RD
    Am J Vet Res; 1997 Apr; 58(4):360-3. PubMed ID: 9099379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternally derived immunity to canine parvovirus infection: transfer, decline, and interference with vaccination.
    Pollock RV; Carmichael LE
    J Am Vet Med Assoc; 1982 Jan; 180(1):37-42. PubMed ID: 7056660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a modified live, canine origin parvovirus vaccine.
    Bass EP; Gill MA; Beckenhauer WH
    J Am Vet Med Assoc; 1982 Nov; 181(9):909-13. PubMed ID: 7141990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum antibody response to canine parvovirus, canine adenovirus-1, and canine distemper virus in dogs with known status of immunization: study of dogs in Sweden.
    Olson P; Klingeborn B; Hedhammar A
    Am J Vet Res; 1988 Sep; 49(9):1460-6. PubMed ID: 3223653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Field evaluation of a canine parvovirus vaccination program, using feline origin modified live virus vaccine.
    Gordon JC; Rogers WA
    J Am Vet Med Assoc; 1982 Jun; 180(12):1429-31. PubMed ID: 6284689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of modified live feline panleukopenia virus vaccine to immunize dogs against canine parvovirus.
    Pollock RV; Carmichael LE
    Am J Vet Res; 1983 Feb; 44(2):169-75. PubMed ID: 6299142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of dogs against canine distemper by vaccination with a canarypox virus recombinant expressing canine distemper virus fusion and hemagglutinin glycoproteins.
    Pardo MC; Bauman JE; Mackowiak M
    Am J Vet Res; 1997 Aug; 58(8):833-6. PubMed ID: 9256965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response of pups with maternal derived antibody to modified-live canine parvovirus vaccine.
    Buonavoglia C; Tollis M; Buonavoglia D; Puccini A
    Comp Immunol Microbiol Infect Dis; 1992 Oct; 15(4):281-3. PubMed ID: 1330425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-year rabies duration of immunity in dogs following vaccination with a core combination vaccine against canine distemper virus, canine adenovirus type-1, canine parvovirus, and rabies virus.
    Lakshmanan N; Gore TC; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
    Vet Ther; 2006; 7(3):223-31. PubMed ID: 17039445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dog response to inactivated canine parvovirus and feline panleukopenia virus vaccines.
    Pollock RV; Carmichael LE
    Cornell Vet; 1982 Jan; 72(1):16-35. PubMed ID: 6279359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity of a low-passage, high-titer modified live canine parvovirus vaccine in pups with maternally derived antibodies.
    Hoare CM; DeBouck P; Wiseman A
    Vaccine; 1997 Feb; 15(3):273-5. PubMed ID: 9139485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A modified live canine parvovirus strain with novel plaque characteristics. I. Viral attenuation and dog response.
    Carmichael LE; Joubert JC; Pollock RV
    Cornell Vet; 1981 Oct; 71(4):408-27. PubMed ID: 7318443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-year duration of immunity in dogs following vaccination against canine adenovirus type-1, canine parvovirus, and canine distemper virus.
    Gore TC; Lakshmanan N; Duncan KL; Coyne MJ; Lum MA; Sterner FJ
    Vet Ther; 2005; 6(1):5-14. PubMed ID: 15906266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral response and protection from experimental challenge following vaccination of raccoon pups with a modified-live canine distemper virus vaccine.
    Paré JA; Barker IK; Crawshaw GJ; McEwen SA; Carman PS; Johnson RP
    J Wildl Dis; 1999 Jul; 35(3):430-9. PubMed ID: 10479076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.